The Evidence REVEAL Study: Exploring the Use of Real-World Evidence and Complex Clinical Trial Design by the European Pharmaceutical Industry.

Clinical Pharmacology and Therapeutics
Peter VarnaiLiana Petrosova

Abstract

The rapid evolution of science and technology allows innovative approaches to generate new types of evidence about the effectiveness of medical product development so as to speed up patients' access to better diagnostics and treatment. Our study explored how two emerging approaches, the use of real-world evidence (RWE) and complex clinical trial (CCT) design, are currently being used by the pharmaceutical industry to support premarketing authorization of medical product development and reviewed the international landscape for regulatory acceptance of such novel approaches. Combining evidence from a literature review, company survey, and interviews with international regulators and experts, we found that 80% of Europe-based pharmaceutical companies have used RWE and 50% have used CCTs, in some capacity. Further, we present case examples of how companies are using these approaches and how international regulators are preparing for such developments. To conclude, we provide a set of recommendations for European industry and regulators to consider so that these novel approaches achieve their full potential within the EU regulatory system.

References

Mar 2, 2017·The New England Journal of Medicine·Hagop KantarjianMax S Topp
Feb 15, 2018·BMJ Open·Laura E BothwellAaron S Kesselheim
May 2, 2018·Therapeutic Innovation & Regulatory Science·Simon Dalla Torre Di SanguinettoClaus Bolte
Jul 22, 2018·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E SkovlundJ F Smyth
Mar 1, 2016·Therapeutic Innovation & Regulatory Science·Min LinEstelle Russek-Cohen
Dec 5, 2018·Therapeutic Innovation & Regulatory Science·Alan HartfordCaroline Morgan
Jan 14, 2019·Clinical Pharmacology and Therapeutics·Jessica M FranklinSebastian Schneeweiss
Apr 4, 2019·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hyun Cheol ChungAlexandra Leary
May 28, 2019·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Alicia GilsenanElizabeth B Andrews
Dec 1, 2019·Clinical Pharmacology and Therapeutics·Elodie Baumfeld Andre, Peter K Honig

❮ Previous
Next ❯

Citations

Oct 25, 2021·Clinical Pharmacology and Therapeutics·Sini Marika EskolaHelga Gardarsdottir

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
Jeremy P BrownAndrew Bate
P & T : a Peer-reviewed Journal for Formulary Management
Sanket S DhruvaNihar R Desai
© 2021 Meta ULC. All rights reserved